Drug Database
Back to search

Czechia· CZ-0223074

KYMRIAH

A tisagenlecleucel product containing tisagenlecleucel, registered in Czechia by Novartis Europharm Limited, Dublin. The same ATC class is registered in 11 of our 19 countries.

ATC L01XL04

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedKYMRIAHATCL01XL04REGISTER NO.CZ-0223074PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tisagenlecleucelAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tisagenlecleucel is registered in 11 of 19 countries.

Countries holding a registration under ATC L01XL04 (tisagenlecleucel), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search tisagenlecleucel products by name

Tisagenlecleucel · ATC L01XL04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
TISAGENLECLEUCEL
Manufacturer
Novartis Europharm Limited, Dublin
Country
Czechia (CZ)
ATC code
L01XL04
ATC class
Tisagenlecleucel
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

60 interactions on record for tisagenlecleucel.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tisagenlecleucel against other medicinesHow interaction checks work

Tisagenlecleucel · interactions on record

60 records

  • 28 severe
  • 32 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tisagenlecleucel in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tisagenlecleucel products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kymriah
  • Liechtenstein · Kymriah
  • Norway · Kymriah

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4c65d749-e699-4237-9149-78a13614b5d5
GET /v1/drugs/4c65d749-e699-4237-9149-78a13614b5d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INF DIS",
  "source": "sukl",
  "strength": "1,2X10^6-6X10^8BUNĚK",
  "pack_size": "1 NEBO VÍCE VAKŮ(50ML)",
  "substance": "TISAGENLECLEUCEL",
  "cz_kod_sukl": "0223074",
  "product_type": "AD/GCM",
  "substance_codes": "21621",
  "registration_state": "R",
  "registration_number": "EU/1/18/1297/001"
}
API referenceMCP serverPlans

See everything about tisagenlecleucel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console